Dr. Liewen studied medicine at the University of Mainz and Frankfurt/Germany and gained clinical experience in neurology. She conducted cancer research at the Oncology Department of the
University of Homburg/Germany and Zurich/Switzerland with focus on antibody target identification and antibody screening. She was a research fellow in Dr. John C Reed Lab at the Burnham
Institute in La Jolla/USA and holds the certificate "Clinical Trial Design and Management" from UCSD Annex. Since 2013 she is CEO of CUREAB.